SUMMER HANSON: Open Payments
NPI 1487311023 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 29 payments from 11 companies in 2025. Trend: 2023 $117 · 2024 $290 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 3 | $256 |
| Janssen Biotech, Inc. | 1 | $119 |
| Dexcom, Inc. | 4 | $90 |
| Lilly USA, LLC | 5 | $87 |
| AstraZeneca Pharmaceuticals LP | 5 | $85 |
| Novo Nordisk Inc | 4 | $74 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $44 |
| ABIOMED | 1 | $26 |
| Exact Sciences Corporation | 1 | $20 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $15 |
Products named: IBSRELA, TREMFYA, Dexcom G6 Transmitter, MOUNJARO, Ozempic, FARXIGA, JARDIANCE, AIRSUPRA.
Industry payments across LA — which companies pay providers there.
